DMRA
Damora Therapeutics, Inc.
NASDAQ: DMRA · HEALTHCARE · BIOTECHNOLOGY
$25.36
-1.17% today
Updated 2026-05-01
Market cap
$1.46B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.98
Dividend yield
—
52W range
$2 – $38
Volume
0.3M
Damora Therapeutics, Inc. (DMRA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-163.80%
ROA
-16.50%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | — | $-15.87M | — | — | — |
| 2019 | — | $-36.51M | — | — | — |
| 2020 | — | $-34.84M | — | — | — |
| 2021 | $0.00 | $-51.75M | — | — | — |
| 2022 | $0.00 | $-61.62M | — | — | — |
| 2023 | $0.00 | $-38.35M | — | — | — |
| 2024 | $0.00 | $-21.44M | — | — | — |
| 2025 | $0.00 | $-209.84M | — | — | — |